U. S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                    FORM 10-Q


              [x] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

                  For the quarterly period ended June 30, 2003
                           Commission File No. 2-70197


                              OCEAN BIO-CHEM, INC.

             (Exact name of registrant as specified in its charter)

          Florida                                            59-1564329
         (State of other jurisdiction of                 (I.R.S. Employer
          incorporation or organization)                 Identification No.)


Registrant's telephone number, including area code - (954) 587-6280

     Indicate  by check mark  whether the  registrant  (1) has filed all reports
required to be filed by Section 13 or 15(d) of the  Securities  Exchange  Act of
1934  during  the  preceding  12 months  (or for such  shorter  period  that the
registrant was required to file such reports),  and (2) has been subject to such
filing requirements for the past 90 days.

                  YES    [  X  ]                       NO        [     ]

     Indicate the number of shares  outstanding of each of the issuer's  classes
of common stock, as of the latest practicable date.

           $.01 Par Value Common Stock, 10,000,000 shares authorized.
            4,960,843 shares issued and outstanding at June 30, 2003



<PAGE>

                      OCEAN BIO-CHEM, INC. AND SUBSIDIARIES

                                      INDEX



   Description                                                        Page

Part I:

  Item 1. - Financial Statements:

      Consolidated balance sheets as of June
          30, 2003 and December 31, 2002                                3

      Consolidated statements of operations for
          the three and six months ended June 30,
          2003 and 2002                                                 4

      Consolidated statements of changes in
          shareholders' equity for the six  months
          ended June 30, 2003 and 2002                                  5

      Consolidated statements of cash flows
          for the six months ended June 30, 2003 and 2002               6

  Item 2. -     Management's Discussion and Analysis
                of Financial Condition and Results of Operations       7-8


Part II:

  Item 1. - Legal Proceedings                                           9
  Item 2. - Changes in Securities                                       9
  Item 3. - Defaults upon Senior Securities                             9
  Item 4. - Submission of Matters to Vote by Security Holders           9
  Item 5. - Other Matters                                               9
  Item 6. - Exhibits and Reports on Form 8-K                            9

Signatures                                                             10

Exhibit 31.0  Certification of CEO                                     11
Exhibit 31.1  Certification of CFO                                     12
Exhibit 32    Certification of CEO and CFO                             13




                                        2
<PAGE>


                         PART I - Financial Information

 Item l.  Financial Statements

                              OCEAN BIO-CHEM, INC.

                                     ASSETS

<TABLE>
<CAPTION>
                                                              JUNE 30,         DECEMBER 31,
                                                               2003               2002
                                                          --------------      -------------
                                                                               (Unaudited)
<S>                                                       <C>                 <C>
Current assets:
Cash                                                      $       53,289      $   1,093,826
Trade accounts receivable net of allowances for
  doubtful accounts of approximately $59,450 and
  $200,700 at June 30, 2003 and December  31,
   2002, respectively                                          3,717,709          3,190,357
Inventories                                                    5,934,067          4,541,150
Prepaid expenses and other current assets                        146,331            129,622
Recoverable income taxes                                           -                240,000
                                                          --------------      -------------
    Total current assets                                       9,851,396          9,194,955
                                                          --------------      -------------

Property, plant and equipment, net                             7,489,054          6,977,003
                                                          --------------      -------------

Other assets:
Funds held in escrow for equipment                               367,873          1,161,194
Trademarks, trade names and patents, net
  of accumulated amortization                                    330,439            330,439
Due from affiliated companies, net                               307,145            612,275
Deposits and other assets                                        296,707            374,371
                                                          --------------      -------------
    Total other assets                                         1,302,164          2,478,279
                                                          --------------      -------------

    Total assets                                          $   18,642,614      $  18,650,237
                                                          ==============      =============

                      LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable - trade                                  $    2,063,065      $   1,833,895
Note payable - bank                                            4,600,000          4,250,000
Current portion of long-term debt                                582,115            601,766
Accrued expenses payable                                         166,030            296,422
                                                          ---------------     --------------
 Total current liabilities                                     7,411,210          6,982,083
                                                          ---------------     --------------

Deferred income taxes payable                                    183,139            183,139
                                                          ---------------     --------------

Long-term debt, less current portion                           6,279,835          6,562,093
                                                          ---------------     --------------

Shareholders' equity:
Common stock - $.01 par value 10,000,000 shares
 authorized, 4,960,843 and 4,805,843 shares
 issued and outstanding at June 30, 2003 and
 December 31, 2002, respectively                                  49,608             48,058
Additional paid-in capital                                     4,409,829          4,341,629
Foreign currency translation adjustment                   (      253,863)     (     303,575)
Retained earnings                                                561,051            845,005
                                                          ---------------     --------------
                                                               4,776,625          4,931,117
Less cost of common stock in treasury,
 7,519 shares at June 30, 2003 and
 December 31, 2002, respectively                          (        8,195)     (       8,195)
                                                          ---------------     --------------
                                                               4,768,430          4,922,922
                                                          ---------------     --------------

Total liabilities and shareholders' equity                $   18,642,614      $  18,650,237
                                                          ===============     ==============
</TABLE>

                                        3



<PAGE>

                              OCEAN BIO-CHEM, INC.
                                AND SUBSIDIARIES
                      CONSOLIDATED STATEMENTS OF OPERATIONS
                                   (Unaudited)
<TABLE>
<CAPTION>
                                              FOR THE THREE MONTHS                    FOR THE SIX MONTHS
                                                 ENDED JUNE 30,                          ENDED JUNE 30,
                                              2003             2002                 2003             2002
                                         ------------       -----------         -----------      ------------

<S>                                      <C>                <C>                 <C>              <C>
Gross sales                              $ 5,462,282        $ 4,674,323         $ 8,688,052      $  8,929,309

Allowances                                    351,531           409,393             706,534           746,403
                                         ------------       -----------         -----------      ------------
Net sales                                   5,110,751         4,264,930           7,981,518         8,182,906
Cost of goods sold                          3,630,147         3,061,118           6,175,783         5,980,076
                                         ------------       -----------         -----------      ------------
Gross profit                                1,480,604         1,203,812           1,805,735         2,202,830
                                         ------------       -----------         -----------      ------------
Costs and expenses:
Advertising and promotion                     189,775           227,370             327,324           380,765
Selling and administrative                    805,967           655,515           1,607,907         1,342,155
Interest expense                               77,583            79,188             147,691           170,161
                                         ------------       -----------         -----------      ------------
    Total cost and expenses                 1,073,325           962,073           2,082,922         1,893,081
                                         ------------       -----------         -----------      ------------

Income (loss) from operations                 407,279           241,739         (   277,187)          309,749
Interest income                                   825                31               3,233                64
                                         ------------       -----------         -----------      ------------
Income (loss) before income taxes             408,104           241,770         (   273,954)          309,813
Provision for income taxes                      -               102,900               -               114,000
                                         ------------       -----------         -----------      ------------
Net income (loss)                             408,104           138,870         (   273,954)          195,813

Other comprehensive income
   (loss) net of income taxes:
Foreign currency translation
  adjustment                                   28,205             7,570              49,712      (      5,852)
                                         ------------       -----------         -----------      -------------
Comprehensive income (loss)              $    436,309       $   146,440         ($  224,242)     $    189,961
                                         ============       ===========         ============     =============
Earnings (loss) per
  common share                           $        .08       $       .03         ($      .06)     $        .05
                                         ============       ===========         ============     =============
</TABLE>


     Earnings per share were  calculated on the basis of 4,823,549 and 4,296,870
weighted average shares of common stock outstanding for the six months and three
months ended June 30, 2003 and 2002, respectively.

     The Company has adopted Statement of Financial Accounting Standards No. 130
which requires items of  comprehensive  income to be stated as part of the basic
financial  statements.  The only items of comprehensive income of the registrant
which  are  reflected  in the  accompanying  financial  statements  are  foreign
currency translation adjustments.

                                        4

<PAGE>

                      OCEAN BIO-CHEM, INC. AND SUBSIDIARIES
                       CONSOLIDATED STATEMENTS OF CHANGES
                             IN SHAREHOLDERS' EQUITY
                            FOR THE SIX MONTHS ENDED
                             JUNE 30, 2003 AND 2002
                                   (UNAUDITED)
<TABLE>
<CAPTION>

                                             Additional      Foreign
                         Common stock         paid-in        currency      Retained     Treasury
                       Shares     Amount      capital       adjustment     earnings       stock       Total
                     ---------    -------    ----------     ----------    ----------    --------    ----------
<S>                  <C>          <C>        <C>            <C>           <C>           <C>         <C>
January 1, 2003      4,805,843    $48,058    $4,341,629     ($ 303,575)   $  845,005    ($ 8,195)   $4,922,922

Net loss                                                                  (  273,954)               (  273,954)

Issuances of stock     155,000      1,550        68,200                                                 69,750

Foreign currency
  translation
  adjustment                                                    49,712                                  49,712
                     ---------    -------    ----------     -----------   ----------    ---------   ----------
June 30, 2003        4,960,843    $49,608    $4,409,829     ($ 253,863)   $  571,051    ($ 8,195)   $4,768,430
                     =========    =======    ==========     ===========   ==========    =========   ==========


January 1, 2002      4,239,889    $42,399    $3,755,219     ($ 262,933)   $1,234,832    ($ 8,195)   $4,761,322


Net income                                                                   195,813                   195,813


Issuances of stock     129,000      1,290        66,435                                                 67,725

Foreign currency
  translation
  adjustment                                                (    5,852)                             (    5,852)
                     ---------    -------    ----------     -----------   ----------    ---------   ----------
June 30, 2002        4,368,889    $43,689    $3,821,654     ($ 268,785)   $1,430,645    ($ 8,195)   $5,019,008
                     =========    =======    ==========     ===========   ==========    =========   ==========


</TABLE>


                                        5


<PAGE>

                              OCEAN BIO-CHEM, INC.
                                AND SUBSIDIARIES
                      CONSOLIDATED STATEMENTS OF CASH FLOWS
                        FOR THE SIX MONTHS ENDED JUNE 30,
                                   (Unaudited)

<TABLE>
<CAPTION>

                                                               2003          2002
                                                            ----------    ----------
<S>                                                         <C>           <C>
Cash flow provided by operating activities:
Net income (loss)                                           ($ 273,954)   $  195,813

Adjustments to reconcile net income
   to net cash provided by operations:
Depreciation and amortization                                  314,924       297,662
Changes in assets and liabilities:
  Decrease (increase) in accounts receivable                (  527,352)      857,474
   (Increase) in inventory                                  (1,392,917)   (  870,661)
   (Increase) decrease in prepaid expenses
     and other current assets                                  223,291    (    4,415)
  (Decrease) in accounts payable,
     accrued expenses and other                                176,442    (  255,374)
                                                            -----------   -----------
      Net cash provided (used) by operating activities      (1,479,566)      220,499
                                                            -----------   -----------
Cash flows from financing activities:
  Net increases under line of credit                           350,000        38,275
  Reduction in advances from affiliates                        305,130        38,336
  Payments on debts, net                                    (  301,909)   (  224,635)
  Common stock transactions                                     69,750        67,725
                                                            -----------   -----------
      Net cash provided (used) by financing activities         422,971    (   80,299)
                                                            -----------   -----------
Cash flows from investing activities:
   Purchases of property, plant, equipment, net
      of funds held in escrow                               (   33,654)   (  105,922)
                                                            -----------   -----------
     Net cash (used) by investing activities                (   33,654)   (  105,922)
                                                            -----------   -----------
  Increase (decrease) in cash prior to effect of
     foreign currency translation adjustment                (1,090,249)       34,278

  Effect of foreign currency translation adjustment
    on cash                                                     49,712    (    5,852)
                                                            -----------   -----------
Net increase (decrease) in cash                             (1,040,537)       28,426

Cash at beginning of period                                  1,093,826        82,000
                                                            -----------   -----------
Cash at end of period                                       $   53,289    $  110,426
                                                            ===========   ===========
Supplemental information:
Cash used for payment of interest during period             $  147,691    $  170,098
                                                            ===========   ===========
Cash used for payment of income taxes during
    period                                                  $    -        $    -
                                                            ===========   ===========

The company had no cash equivalents at June 30, 2003 and 2002.
</TABLE>


                                        6


<PAGE>

                              OCEAN BIO-CHEM, INC.
                                AND SUBSIDIARIES
                 NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

     1. The information contained in this report is unaudited,  but reflects all
adjustments  which are, in the opinion of the  management,  necessary for a fair
statement of results of the interim periods, consisting only of normal recurring
accruals. The results for such interim periods are not necessarily indicative of
results to be expected for the full year.

     Certain  financial  statement items for the three and six months ended June
30, 2002 have been reclassified to conform with the 2003 presentation.

ITEM 2        MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
              CONDITION AND RESULTS OF OPERATIONS

Liquidity and Capital Resources

     The  primary  sources of the  Registrant's  liquidity  are its  operations,
short-term  borrowings  from a commercial  bank pursuant to a revolving  line of
credit arrangement,  and other borrowings.  Advances under the Registrant's line
are secured by trade  receivables and  inventories,  and can aggregate a maximum
amount of $5,000,000  bearing interest at the lender's prime rate plus .25%. The
line, which matures on May 31, 2004, requires the Registrant to maintain certain
financial  ratios. As of June 30, 2003, the amount  outstanding  pursuant to the
working capital line of credit was $4,600,000.

     During July,  2002,  the Registrant  finalized the working  capital line of
credit  discussed in the preceding  paragraph as well as an  Industrial  Revenue
Bond  financing  issued  through  the city of  Montgomery,  AL in the  amount of
$3,500,000  to be utilized for a plant  expansion  and related  equipment at the
Registrant's Montgomery, AL facility. Such financing was obtained with favorable
interest rate terms which float with current  conditions.  The present  interest
rate is approximately 1% per year.

     The  Registrant  is involved in making  sales in the  Canadian  market and,
accordingly, is subject to fluctuations of the Canadian currency. The Registrant
does not engage in currency hedging and deals with such risk as a pricing issue.

Results of Operations For The Three Month Period April 1- June 30:

     Gross sales increased approximately 14.4% or $788,000 for the quarter ended
June  30,  2003  when  compared  to the  same  quarter  of the  preceding  year.
Management  attributes this increase  substantially from recently introduced new
marine oil products and, in part due to the timing of customer orders  comparing
the 2003 and 2002 periods.

     Cost of goods sold  decreased as a percentage  of net sales when  comparing
the  quarter  ended  June 30,  2003 with the  comparable  quarter  in 2002.  The
percentages  were  71.0% and 71.8% for the  respective  quarters.  This  change,
although not  significant,  represents  an  improvement  and is attributed to an
on-going effort to monitor costs.

     Selling and  administrative  expenses increased  approximately  $150,500 or
18.7%comparing  the quarters ended June 30, 2003 and June 30, 2002.  Such change
was  primarily  due to  increased  personnel  costs and other  normal  recurring
increases in operating expenses.



                                        7


<PAGE>


     Advertising  and  promotion  decreased   approximately   $37,600  or  19.9%
comparing the three months ended June 30, 2003 and 2002. This resulted primarily
from decreased co-op  advertising  offered  certain  customers and the timing of
various advertising programs in 2003.

     Interest expense was substantially  unchanged  comparing the quarters ended
June 30,  2003 and 2002 and  amounted  to  approximately  $77,600  and  $79,200,
respectively.


Results of Operations For the Six Month Period January 1 - June 30:

     Gross Sales decreased 2.7% or approximately $241,000 when comparing the six
month periods of 2003 and 2002.  Management attributes this to a very weak first
quarter caused by weather problems  throughout the United States and a change in
ordering policies by one of the Registrant's larger customers. During the second
quarter of 2003, the Registrant benefited from both new marine oil product sales
as well as resumption of ordering from the aforementioned customer.

     Cost of goods sold  increased as a percentage  of net sales when  comparing
the six  months  ended June 30,  2003 with the  comparable  period in 2002.  The
percentages  were 77.4% and 73.1% for the six month periods ended 2003 and 2002,
respectively.   This  change  resulted  from  various  factors,  some  of  which
negatively   impacted   margins  and  others  which   mitigated  these  factors.
Specifically,  petroleum  products  have  costs  which  are  higher  than  those
experienced  in prior  periods  and  currently  represent  a higher  portion  of
manufacturing efforts. In addition, a price increase was passed along on certain
products,  and margins are  impacted by  spreading  fixed  overheads  over lower
revenues.

     Advertising and promotion  expenses  decreased  approximately  $53,400 when
comparing  the six months  ended June 30, 2003 to the six months  ended June 30,
2002. This was primarily due to a planned decrease in the advertising budget.

     Selling and administrative expenses increased for the six months ended June
30,  2003 by  approximately  $ 265,800 or 19.9% when  compared to the six months
ended June 30, 2002. Such change was primarily due to increased  personnel costs
and other normal recurring increases in operating expenses.

     Interest  expense  decreased  during  2003 by  approximately  $22,400  when
compared to the same six month period of 2002.  This change was primarily due to
the impact of decreasing interest rates.

Forward-looking Statements:

     Certain   statements   contained  herein,   including  without   limitation
expectations   as  to   future   sales   and   operating   results,   constitute
forward-looking statements pursuant to the safe harbor provisions of the Private
Securities  Litigation  Reform Act of 1995.  For this  purpose,  any  statements
contained  in this  report that are not  statements  of  historical  fact may be
deemed  forward-looking  statements.  Without  limiting  the  generality  of the
foregoing,  words  such as  "may",  "will",  "expect",  "anticipate",  "intend",
"could" or the negative other variations  thereof or comparable  terminology are
intended to identify forward-looking statements.  These statements involve known
and  unknown  risks,  uncertainties  and other  factors  which may cause  actual
results,  performance or achievements of the Company to be materially  different
from any future  results,  performance or  achievements  expressed or implied by
such forward-looking statements.  Factors which may affect the Company's results
include,  but are not limited to, the highly competitive nature of the Company's
industry;  reliance  on certain  key  customers;  consumer  demand  for  marine,


                                       8

<PAGE>
receational  vehicle  and  automotive  products;   advertising  and  promotional
efforts,  and other  factors.  The Company will not undertake  and  specifically
declines any obligation to update or correct any  forward-looking  statements to
reflect events or circumstances  after the date of such statements or to reflect
the occurrence of anticipated or unanticipated events.

PART II:  OTHER INFORMATION

     Item l - Legal  Proceedings:  See Registrant's Form 10-K for the year ended
December 31, 2002.

     Item 2 - Changes in  Securities:  On April 1, 2003,  155,000  shares of the
Registrant's common stock were issued pursuant to an employee bonus program.

     Item 3 - Defaults Upon Senior Securities: Not applicable

     Item 4 -  Submission  of Matters to Vote of Security  Holders:  On June 19,
2003, at the Registrant's annual meeting of shareholders, seven directors; Peter
Dornau,  Edward Anchel,  Jeffrey Tieger, Laz Schneider,  James Kolisch,  John B.
Turner, and Sonia B. Beard were elected.  Shareholders also approved  Berkovits,
Lago & Co., LLP, Certified Public Accountants,  as independent  auditors for the
year ending December 31, 2003 and ratified the adoption of a Qualified Incentive
Stock  Option Plan and a  Non-qualified  Stock Option Plan.  The  tabulation  of
voting for the foregoing was as follows:
<TABLE>
<CAPTION>


                                            For          Against           Abstain
                                         ---------     -----------      ------------
           <S>                           <C>           <C>              <C>
           Peter Dornau                  3,276,926           1,603             3,334
           Edward Anchel                 3,276,926           1,603             3,334
           Jeffrey Tieger                3,276,926           1,603             3,334
           Laz Schneider                 3,276,926           1,603             3,334
           James Kolisch                 3,276,926           1,603             3,334
           John B. Turner                3,276,926           1,603             3,334
           Sonia B. Beard                3,276,926           1,603             3,334

           Berkovits, Lago
            & Co.,LLP, CPA's             4,629,299          15,703             4,823

           Qualified Incentive
             Stock Option Plan           3,276,926          12,892         1,360,007

           Non-qualified Stock
             Option Plan                 3,266,504          21,271         1,362.050

</TABLE>


     Item 5 - Other Matters: Not applicable

     Item 6 - Exhibits:

     (A) Exhibits - Exhibits 31.0 and 31.1, Executive Officer Certifications
                    Exhibit 32 - Certification of CEO and CFO furnished, but not
                                         filed

     (B) Reports on Form 8-K - Not applicable



                                        9
<PAGE>


                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.



                                                    OCEAN BIO-CHEM, INC.

Date: August 13, 2003                                /s/ Peter Dornau
                                                    -------------------------
                                                    Peter G. Dornau
                                                    Chairman of the Board and
                                                    Chief Executive Officer


                                                     /s/ Edward Anchel
                                                    -------------------------
                                                    Edward Anchel
                                                    Chief Financial Officer



























                                       10


<PAGE>
                                                                      EXHIBIT 31
                                 CERTIFICATION


                 I, Peter Dornau certify that:

     1. I have reviewed this  quarterly  report on Form 10-Q of Ocean  Bio-Chem,
Inc. as of and for the periods ended June 30, 2003;

     2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact  necessary to make
the statements made, in light of the  circumstances  under which such statements
were made, not misleading  with respect to the periods covered by this
report;

     3. Based on my knowledge,  the financial  statements,  and other  financial
information included in this report, fairly present in all material respects the
financial  condition,  results of operations and cash flows of the Registrant as
of, and for, the periods presented in this report;

     4. The  Registrant's  other  certifying  officer and I are  responsible for
establishing and maintaining  disclosure  controls and procedures (as defined in
Exchange Act Rules 13a - 15(e) and 15d - 15(e)) for the Registrant and have:

     a)  Designed  such  disclosure  controls  and  procedures,  or caused  such
disclosure  controls and  procedures to be designed  under our  supervision,  to
ensure that  material  information  relating to the  Registrant,  including  its
consolidated subsidiaries,  is made known to us by others within those entities,
particularly during the period in which this quarterly report is being prepared;

     b) Evaluated the effectiveness of the Registrant's  disclosure controls and
procedures and presented in this report our conclusions  about the effectiveness
of the disclosure  controls and procedures , as of the end of the period covered
by this report based on such evaluation; and

     c) Disclosed in this report any change in the Registrant's internal control
over  financial  reporting  that occurred  during the  Registrant's  most recent
fiscal  quarter  that  has  materially  affected,  or is  reasonably  likely  to
materially affect, the Registrant's  internal control over financial  reporting;
and

     5. The registrant's other certifying officer and I have disclosed, based on
our most recent evaluation of internal control over financial reporting,  to the
Registrant's auditors and the audit committee of Registrant's board of directors
(or persons performing the equivalent function):

     a) All significant  deficiencies  and material  weaknesses in the design or
operation of internal  control over  financial  reporting  which are  reasonably
likely  to  adversely  affect  the  Registrant's  ability  to  record,  process,
summarize and report financial information; and

     b) Any fraud,  whether or not material,  that involves  management or other
employees who have a significant role in the Registrant's  internal control over
financial reporting.

         OCEAN BIO-CHEM, INC.

         Date:    August 13, 2003                      /s/ Peter Dornau
                                                       ------------------------
                                                       Peter G. Dornau
                                                       Chairman of the Board of
                                                       Directors  and Chief
                                                       Executive Officer


<PAGE>
                                                                    EXHIBIT 31.1
                                 CERTIFICATION

                 I, Edward Anchel certify that:

     1. I have reviewed this  quarterly  report on Form 10-Q of Ocean  Bio-Chem,
Inc. as of and for the periods ended June 30, 2003;

     2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact  necessary to make
the statements made, in light of the  circumstances  under which such statements
were made, not misleading  with respect to the periods covered by this
report;

     3. Based on my knowledge,  the financial  statements,  and other  financial
information included in this report, fairly present in all material respects the
financial  condition,  results of operations and cash flows of the Registrant as
of, and for, the periods presented in this report;

     4. The  Registrant's  other  certifying  officer and I are  responsible for
establishing and maintaining  disclosure  controls and procedures (as defined in
Exchange Act Rules 13a - 15(e) and 15d - 15(e)) for the Registrant and have:

     a)  Designed  such  disclosure  controls  and  procedures,  or caused  such
disclosure  controls and  procedures to be designed  under our  supervision,  to
ensure that  material  information  relating to the  Registrant,  including  its
consolidated subsidiaries,  is made known to us by others within those entities,
particularly during the period in which this quarterly report is being prepared;

     b) Evaluated the effectiveness of the Registrant's  disclosure controls and
procedures and presented in this report our conclusions  about the effectiveness
of the disclosure  controls and procedures , as of the end of the period covered
by this report based on such evaluation; and

     c) Disclosed in this report any change in the Registrant's internal control
over  financial  reporting  that occurred  during the  Registrant's  most recent
fiscal  quarter  that  has  materially  affected,  or is  reasonably  likely  to
materially affect, the Registrant's  internal control over financial  reporting;
and

     5. The registrant's other certifying officer and I have disclosed, based on
our most recent evaluation of internal control over financial reporting,  to the
Registrant's auditors and the audit committee of Registrant's board of directors
(or persons performing the equivalent function):

     a) All significant  deficiencies  and material  weaknesses in the design or
operation of internal  control over  financial  reporting  which are  reasonably
likely  to  adversely  affect  the  Registrant's  ability  to  record,  process,
summarize and report financial information; and

     b) Any fraud,  whether or not material,  that involves  management or other
employees who have a significant role in the Registrant's  internal control over
financial reporting.


         OCEAN BIO-CHEM, INC.

         Date:    August 13, 2003                      /s/ Edward Anchel
                                                       ------------------------
                                                       Edward Anchel
                                                       Chief Financial Officer


<PAGE>

                                                                      Exhibit 32



                                  CERTIFICATION

     Pursuant  to  18U.S.C.Section  1350,  the  undersigned  officers  of  Ocean
Bio-Chem,  Inc. (the  "Company"),  hereby  certify that the Company's  Quarterly
Report on Form 10-Q for the  quarter  ended June 30, 2003 (the  "Report")  fully
complies with the requirements of Section 13(a) or 15(d), as applicable,  of the
Securities Exchange Act of 1934 and that the information contained in the Report
fairly presents,  in all material respects,  the financial condition and results
of operation of the Company.

Dated: August 13, 2003


                                                       /s/ Peter Dornau
                                                       ------------------------
                                                       Peter G. Dornau
                                                       Chairman of the Board of
                                                       Directors  and Chief
                                                       Executive Office




                                                       /s/ Edward Anchel
                                                       ------------------------
                                                       Edward Anchel
                                                       Chief Financial Officer